Dr. Reddy's Laboratories
RDY
#1699
Rank
S$15.38 B
Marketcap
S$18.39
Share price
0.35%
Change (1 day)
-4.47%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Cash on Hand

Cash on Hand as of September 2025 : S$1.01 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company has S$1.01 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dr. Reddy's Laboratories - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31S$0.91 B-30.9%
2024-03-31S$1.31 B31.66%
2023-03-31S$1.00 B26.38%
2022-03-31S$0.79 B24.6%
2021-03-31S$0.63 B30.76%
2020-03-31S$0.48 B0.61%
2019-03-31S$0.48 B14.35%
2018-03-31S$0.42 B8.14%
2017-03-31S$0.39 B-51.98%
2016-03-31S$0.81 B-6.96%
2015-03-31S$0.87 B24.24%
2014-03-31S$0.70 B39.21%
2013-03-31S$0.50 B12.63%
2012-03-31S$0.44 B174.66%
2011-03-31S$0.16 B-48.8%
2010-03-31S$0.31 B73.3%
2009-03-31S$0.18 B-56.06%
2008-03-31S$0.41 B-33.9%
2007-03-31S$0.63 B367.32%
2006-03-31S$0.13 B-62.94%
2005-03-31S$0.36 B37.17%
2004-03-31S$0.26 B-0.91%
2003-03-31S$0.26 B39.49%
2002-03-31S$0.19 B939.26%
2001-03-31S$18.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
S$19.41 B 1,806.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.85 B 180.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$5.75 B 465.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
S$12.63 B 1,141.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$13.54 B 1,230.10%๐Ÿ‡ซ๐Ÿ‡ท France